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Prader-Willi syndrome (PWS) is caused by loss of func-
tion of genes on chromosome 15; most cases occur
when a segment of the paternal chromosome 15 is
absent/inactivated. Recently few cases have been identi-
fied with truncating mutations in MAGEL2 gene (Chro-
mosome 15). We present clinical features and molecular
genetic analysis on 6 patients with features of PWS
using MS-MLPA.
Four boys and 2 girls (age 8-15 years) presenting with
obesity, facial features of PWS, developmental delay,
snoring and hypogonadism were referred for genetic
testing. DNA was extracted from peripheral blood and
MS-MLPA was carried out using MS-MLPA Probemix
(ME028) from MRC Holland[1]. Data analyses were per-
formed using Coffalyser Software (MRC Holland). MS-
MLPA was used to detect copy number changes and
determine CpG island methylation status of 15q11.3-13
locus in semi-quantitative manner.
Of six patients, no genetic defect was detected in one.
Two patients’ DNA on MLPA analysis showed 50%
reduction in peak intensities (compared to healthy con-
trol) of 29 probes in the targeted 15q11.3-13 region
indicating heterozygous deletion of that region. The sin-
gle copy that was present in these patients was
imprinted and likely to be silenced. In the fourth
patient, no detectable deletion was found, however,
comparative MS-MLPA analysis of this sample pre- and
post- methylation-specific restriction digestion showed
approximately 100% relative methylation for the 5
probes specific to the imprinted regions (these are 50%
in healthy individuals). Both copies of the analyzed
region were imprinted and likely to be silenced (most
likely due to maternal uniparental disomy). For the last
two patients, while no deletion was found, both samples
showed hypomethylation (0% methylation) of one probe
in necdin-encoding gene (NDN) locus (for this locus,
expected methylation for healthy controls is between
30%-50%). We are investigating the relevance of these
data.
Our MS-MLPA results in 6 patients with clinical fea-
tures of PWS indicate that two cases had deletions, one
had a maternal uniparental disomy or an imprinting
defect, two had hypomethylation of the NDN locus and
one did not show any defect.
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